- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
Following the news today that Volvo Cars will build a third European manufacturing plant in Slovakia; David Leggett, Automotive Analyst at GlobalData, a leading data and analytics company, offers his view: “This is a smart move for Volvo Cars to add much needed future production capacity in electric vehicles in Europe in a low cost […]
Venture financing deal value for US-headquartered biotechs decreased by 46% in Q1 2022 compared to Q1 2021, finds GlobalData
Venture financing deal value for US-headquartered biotech companies decreased by 46% in Q1 2022 compared to Q1 2021, according to GlobalData. The leading data and analytics company notes that this decrease was due to venture capital firms becoming more selective in their investments due to the current economic and geopolitical uncertainties. Mariam Shwea, MPH, Business […]
Jobs related to ‘Deal Making’ as a theme increase by 427% in Q1 2022, finds GlobalData
The number of job postings that mentioned ‘Deal Making’ as a theme grew by 427% in Q1 2022 verses Q4 2021, according to leading data and analytics company GlobalData. This finding was identified as part of research into the growth of companies using various themes within job postings. Trending themes included ‘Ecommerce’, ‘Artificial Intelligence’, ‘Environment’, […]
Europe’s innovator drug venture financing loses pace with the US while entering bear market, says GlobalData
The biotech venture financing gap between Europe and the US is growing, with Europe on average receiving five times less per quarter compared to its US counterpart since 2017, says GlobalData. According to the leading data and analytics company, biotechs headquartered in Europe had $56 billion less venturing financing for innovator drugs than the US […]
Cardiomyopathies market set to reach $5.2 billion by 2031 driven by blockbuster obstructive HCM drugs, forecasts GlobalData
The cardiomyopathies market is set to grow from $1.6 billion in 2021 to $5.2 billion in 2031 across the seven major markets (7MM*) at a compound annual growth rate (CAGR) of 12.4%, according to GlobalData. The leading data and analytics company notes that growth in the US, 5EU*, and Japan will largely be driven by late-stage pipeline […]
Rune Labs’ use of Apple Watch to track Parkinson’s symptoms will be game changing for patients, says GlobalData
Rune Labs receiving clearance from the US Food and Drug Administration (FDA) to use Apple Watch to track symptoms of Parkinson’s disease is exciting news for patients, as doctors can combine data to better personalize treatment for individual patients, says GlobalData, a leading data and analytics company. Rebecca Wu, Medical Analyst at GlobalData, comments: “This is […]
Noon partnership with Newcastle United provides ‘Middle Eastern Amazon’ with a global platform, says GlobalData
Following the news that PIF-backed Noon has become Newcastle United’s shirt sleeve partner; Conrad Wiacek, Head of Sport Analysis at GlobalData, a leading data and analytics company, offers his view: “While the issue of Saudi involvement in the takeover and ownership of Newcastle United is still unclear, the deal between PIF-backed Noon and the club […]
Sanofi and Regeneron’s additional label expansion for Dupixent reinforces its dominance in the atopic dermatitis market, says GlobalData
The Food and Drug Administration’s (FDA) approval for Sanofi and Regeneron’s interleukin (IL)-4/13 inhibitor, Dupixent (dupilumab), for the treatment of children ages 6 months to 5 years with moderate-to-severe atopic dermatitis (AD) earlier this month, has solidified first-mover advantage for Dupixent and reinforces its market-leading position for the treatment of moderate-to-severe AD, says GlobalData, a […]
Lilly’s Mounjaro to become a market leading therapy for T2D and obesity, says GlobalData
With strong results from its SURPASS program for gastric inhibitory peptide/glucagon-like peptide-1 receptor (GIP/GLP-1) dual agonist Mounjaro (tirzepatide) for the treatment of type 2 diabetes (T2D), Lilly can expect Mounjaro to gain a significant share of the GLP-1 and wider T2D and obesity markets, says GlobalData. The leading data and analytics company notes that Mounjaro […]
FDA approval of VisAR will enable medical device companies to capitalize on AR market set to be worth $152 billion by 2030, says GlobalData
Investing in augmented reality (AR) is a wise long-term investment for medical device companies, as the global AR market is estimated to be worth $152 billion by 2030 with enterprise AR making up 65% of total revenue, says GlobalData. The leading data and analytics company points out a recent example of Novarad’s VisAR, a fully […]
Geography and geopolitics define Spain’s failure to meet NATO’s 2% spending target, says GlobalData
Spain is set to increase its defense spending over the next five years to reach $16.8 billion by 2027, according to GlobalData. However, the leading data and analytics company notes that the country will not meet NATO’s target of spending 2% of its GDP on defense. Spain’s percentage of GDP spent on defense will remain […]
AI set to disrupt women’s healthcare as AI investment to more than double in medical devices industry to $500 million by 2024, says GlobalData
Artificial intelligence (AI) is predicted to disrupt the women’s healthcare market in the US, as medical device companies are forecast to spend $500 million on AI platforms by 2024, up from $200 million in 2019, and representing an impressive compound annual growth rate (CAGR) of 20.6%, according to GlobalData. The leading data and analytics company notes that diagnostic tools such as Ultrasound AI’s Preterm AI (PAI), which will be used to predict preterm birth […]
Travel & tourism deal activity registers marginal growth of 1.4% in May 2022, finds GlobalData
Deal activity in the global travel and tourism sector mostly remained flat during May 2022 compared to the previous month, says GlobalData. According to the leading data and analytics company’s Financial Deals Database, a total of 73 deals* were announced in the global travel and tourism sector during May, which is a growth of 1.4% over 72 […]
Israel is establishing itself as a prominent player in the electronic warfare sector, says GlobalData
Following the news that Israel Aerospace Industries (IAI) has been awarded a contract for its Scorpius-SP Airborne Self Protection Jammer by an undisclosed Asian country; Tushar Mangure, Defense Analyst at GlobalData, a leading data and analytics company, offers his view: “The Scorpius-SP jammer’s ability to simultaneously scan a large area for potential Surface-to-Air and Air-to-Air […]
US-based start-ups raised $106.1 billion VC funding between January and May 2022, finds GlobalData
A total of 4,791 venture capital (VC) funding deals were announced in the US during January to May 2022 while the disclosed funding value of these deals stood at $106.1 billion, according to GlobalData. An analysis of the leading data and analytics company’s Financial Deals Database reveals that the US was the only country to surpass the […]
South Korea’s fixed communication service revenue to decline at a CAGR of 1.4% by 2026, finds GlobalData
Fixed communication service revenue in South Korea is expected to decline from $6.5 billion in 2021 to $6.1 billion in 2026 at a compound annual growth rate (CAGR) of 1.4%, according to GlobalData. The leading data and analytics company notes that this decrease is mainly due to the continued decline in voice subscriptions and slowing […]
Gorillas bets on consumers maintaining their online shopping habits during COVID-19 as it launches private label range, says GlobalData
Gorillas’ launch of a private label range is sure to resonate with the 54%* of Europeans who are currently in a financial pinch yet still looking for convenient shopping options, says GlobalData. The leading data and analytics company notes that as the COVID-19 pandemic and the cost-of-living crisis have changed consumer behavior, retailers such as […]
IVD market is anticipated to decline at a CAGR of 4% by 2030, according to GlobalData
Following a boost in the use of in-vitro diagnostics (IVD) due to COVID-19 testing, the IVD market is now expected to take a fall, according to GlobalData. The leading data and analytics company anticipates that the market was valued at $84.3 billion in 2021 and will decline at a compound annual growth rate (CAGR) of 4% […]
NHS Federated Data Platform contract could quadruple Palantir’s UK public sector revenue, says GlobalData
With US data giant Palantir Technologies expected to win a £360 million contract with the NHS Federated Data Platform (FDP) across the UK public sector; Dean Sabri, Principal Analyst for UK Health and Social Care at GlobalData, a leading data and analytics company, offers his view: “Winning the £360 million FDP contract would represent a massive increase […]
Artificially intelligent X-rays to improve patient outcomes in the US, says GlobalData
We can expect further artificial intelligence (AI) medical device partnerships in the coming years, according to GlobalData, as the pandemic has accelerated the use of digital health tools and technologies. The leading data and analytics company highlights the recent partnership between AI solutions provider Aidoc and medtech company Gleamer, which aims to develop AI X-ray […]